Literature DB >> 26963284

The complex behavioral phenotype of 15q13.3 microdeletion syndrome.

Mark N Ziats1, Robin P Goin-Kochel2,3, Leandra N Berry2,3, May Ali4,5, Jun Ge4, Danielle Guffey6, Jill A Rosenfeld4, Patricia Bader7, Michael J Gambello8, Varina Wolf9, Lynette S Penney10, Ryan Miller11, Robert Roger Lebel11, Jeffrey Kane12, Kristine Bachman13, Robin Troxell14, Gary Clark9, Charles G Minard6, Pawel Stankiewicz4, Arthur Beaudet4, Christian P Schaaf4,5.   

Abstract

BACKGROUND: Chromosome 15q13.3 represents a hotspot for genomic rearrangements due to repetitive sequences mediating nonallelic homologous recombination. Deletions of 15q13.3 have been identified in the context of multiple neurological and psychiatric disorders, but a prospective clinical and behavioral assessment of affected individuals has not yet been reported.
METHODS: Eighteen subjects with 15q13.3 microdeletion underwent a series of behavioral assessments, along with clinical history and physical examination, to comprehensively define their behavioral phenotypes.
RESULTS: Cognitive deficits are the most prevalent feature in 15q13.3 deletion syndrome, with an average nonverbal IQ of 60 among the patients studied. Autism spectrum disorder was highly penetrant, with 31% of patients meeting clinical criteria and exceeding cutoff scores on both ADOS-2 and ADI-R. Affected individuals exhibited a complex pattern of behavioral abnormalities, most notably hyperactivity, attention problems, withdrawal, and externalizing symptoms, as well as impairments in functional communication, leadership, adaptive skills, and activities of daily living.
CONCLUSIONS: The 15q13.3 deletion syndrome encompasses a heterogeneous behavioral phenotype that poses a major challenge to parents, caregivers, and treating providers. Further work to more clearly delineate genotype-phenotype relationships in 15q13.3 deletions will be important for anticipatory guidance and development of targeted therapies.Genet Med 18 11, 1111-1118.

Entities:  

Mesh:

Year:  2016        PMID: 26963284     DOI: 10.1038/gim.2016.9

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  27 in total

1.  Structures and molecular mechanisms for common 15q13.3 microduplications involving CHRNA7: benign or pathological?

Authors:  Przemyslaw Szafranski; Christian P Schaaf; Richard E Person; Ian B Gibson; Zhilian Xia; Sangeetha Mahadevan; Joanna Wiszniewska; Carlos A Bacino; Seema Lalani; Lorraine Potocki; Sung-Hae Kang; Ankita Patel; Sau Wai Cheung; Frank J Probst; Brett H Graham; Marwan Shinawi; Arthur L Beaudet; Pawel Stankiewicz
Journal:  Hum Mutat       Date:  2010-07       Impact factor: 4.878

2.  Deletions flanked by breakpoints 3 and 4 on 15q13 may contribute to abnormal phenotypes.

Authors:  Jill A Rosenfeld; Lindsey E Stephens; Justine Coppinger; Blake C Ballif; Joe J Hoo; Beatrice N French; Valerie C Banks; Wendy E Smith; David Manchester; Anne Chun-Hui Tsai; Katrina Merrion; Roberto Mendoza-Londono; Lucie Dupuis; Roger Schultz; Beth Torchia; Trilochan Sahoo; Bassem Bejjani; David D Weaver; Lisa G Shaffer
Journal:  Eur J Hum Genet       Date:  2011-01-19       Impact factor: 4.246

3.  Homozygous deletion of chromosome 15q13.3 including CHRNA7 causes severe mental retardation, seizures, muscular hypotonia, and the loss of KLF13 and TRPM1 potentially cause macrocytosis and congenital retinal dysfunction in siblings.

Authors:  Malte Spielmann; Gabriele Reichelt; Christoph Hertzberg; Marc Trimborn; Stefan Mundlos; Denise Horn; Eva Klopocki
Journal:  Eur J Med Genet       Date:  2011-04-29       Impact factor: 2.708

Review 4.  Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease.

Authors:  Tanya L Wallace; Richard H P Porter
Journal:  Biochem Pharmacol       Date:  2011-07-02       Impact factor: 5.858

5.  Delineation of 15q13.3 microdeletions.

Authors:  A Masurel-Paulet; J Andrieux; P Callier; J M Cuisset; C Le Caignec; M Holder; C Thauvin-Robinet; B Doray; E Flori; M P Alex-Cordier; M Beri; O Boute; B Delobel; A Dieux; L Vallee; S Jaillard; S Odent; B Isidor; C Beneteau; J Vigneron; F Bilan; B Gilbert-Dussardier; C Dubourg; A Labalme; C Bidon; A Gautier; P Pernes; J M Pinoit; F Huet; F Mugneret; B Aral; P Jonveaux; D Sanlaville; L Faivre
Journal:  Clin Genet       Date:  2010-02-09       Impact factor: 4.438

Review 6.  The human clinical phenotypes of altered CHRNA7 copy number.

Authors:  Madelyn A Gillentine; Christian P Schaaf
Journal:  Biochem Pharmacol       Date:  2015-06-18       Impact factor: 5.858

Review 7.  Neurodevelopmental disorders involving genomic imprinting at human chromosome 15q11-q13.

Authors:  Stormy J Chamberlain; Marc Lalande
Journal:  Neurobiol Dis       Date:  2010-03-18       Impact factor: 5.996

8.  A small homozygous microdeletion of 15q13.3 including the CHRNA7 gene in a girl with a spectrum of severe neurodevelopmental features.

Authors:  Jun Liao; Stephanie J DeWard; Suneeta Madan-Khetarpal; Urvashi Surti; Jie Hu
Journal:  Am J Med Genet A       Date:  2011-10-11       Impact factor: 2.802

9.  Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3.

Authors:  Nigel M Williams; Barbara Franke; Eric Mick; Richard J L Anney; Christine M Freitag; Michael Gill; Anita Thapar; Michael C O'Donovan; Michael J Owen; Peter Holmans; Lindsey Kent; Frank Middleton; Yanli Zhang-James; Lu Liu; Jobst Meyer; Thuy Trang Nguyen; Jasmin Romanos; Marcel Romanos; Christiane Seitz; Tobias J Renner; Susanne Walitza; Andreas Warnke; Haukur Palmason; Jan Buitelaar; Nanda Rommelse; Alejandro Arias Vasquez; Ziarih Hawi; Kate Langley; Joseph Sergeant; Hans-Christoph Steinhausen; Herbert Roeyers; Joseph Biederman; Irina Zaharieva; Hakon Hakonarson; Josephine Elia; Anath C Lionel; Jennifer Crosbie; Christian R Marshall; Russell Schachar; Stephen W Scherer; Alexandre Todorov; Susan L Smalley; Sandra Loo; Stanley Nelson; Corina Shtir; Philip Asherson; Andreas Reif; Klaus-Peter Lesch; Stephen V Faraone
Journal:  Am J Psychiatry       Date:  2012-02       Impact factor: 18.112

10.  Refining analyses of copy number variation identifies specific genes associated with developmental delay.

Authors:  Bradley P Coe; Kali Witherspoon; Jill A Rosenfeld; Bregje W M van Bon; Anneke T Vulto-van Silfhout; Paolo Bosco; Kathryn L Friend; Carl Baker; Serafino Buono; Lisenka E L M Vissers; Janneke H Schuurs-Hoeijmakers; Alex Hoischen; Rolph Pfundt; Nik Krumm; Gemma L Carvill; Deana Li; David Amaral; Natasha Brown; Paul J Lockhart; Ingrid E Scheffer; Antonino Alberti; Marie Shaw; Rosa Pettinato; Raymond Tervo; Nicole de Leeuw; Margot R F Reijnders; Beth S Torchia; Hilde Peeters; Brian J O'Roak; Marco Fichera; Jayne Y Hehir-Kwa; Jay Shendure; Heather C Mefford; Eric Haan; Jozef Gécz; Bert B A de Vries; Corrado Romano; Evan E Eichler
Journal:  Nat Genet       Date:  2014-09-14       Impact factor: 38.330

View more
  20 in total

1.  Systematic Review and Meta-Analysis of the Clinical Utility of the ADOS-2 and the ADI-R in Diagnosing Autism Spectrum Disorders in Children.

Authors:  Jenna B Lebersfeld; Marissa Swanson; Christian D Clesi; Sarah E O'Kelley
Journal:  J Autism Dev Disord       Date:  2021-01-21

Review 2.  Unraveling the genetic architecture of copy number variants associated with schizophrenia and other neuropsychiatric disorders.

Authors:  Timothy P Rutkowski; Jason P Schroeder; Georgette M Gafford; Stephen T Warren; David Weinshenker; Tamara Caspary; Jennifer G Mulle
Journal:  J Neurosci Res       Date:  2016-11-08       Impact factor: 4.164

3.  CHRNA7 copy number gains are enriched in adolescents with major depressive and anxiety disorders.

Authors:  Madelyn A Gillentine; Ricardo Lozoya; Jiani Yin; Christopher M Grochowski; Janson J White; Christian P Schaaf; Chadi A Calarge
Journal:  J Affect Disord       Date:  2018-07-11       Impact factor: 4.839

4.  Functional Consequences of CHRNA7 Copy-Number Alterations in Induced Pluripotent Stem Cells and Neural Progenitor Cells.

Authors:  Madelyn A Gillentine; Jiani Yin; Aleksandar Bajic; Ping Zhang; Steven Cummock; Jean J Kim; Christian P Schaaf
Journal:  Am J Hum Genet       Date:  2017-11-09       Impact factor: 11.025

5.  The Cognitive and Behavioral Phenotypes of Individuals with CHRNA7 Duplications.

Authors:  M A Gillentine; L N Berry; R P Goin-Kochel; M A Ali; J Ge; D Guffey; J A Rosenfeld; V Hannig; P Bader; M Proud; M Shinawi; B H Graham; A Lin; S R Lalani; J Reynolds; M Chen; T Grebe; C G Minard; P Stankiewicz; A L Beaudet; C P Schaaf
Journal:  J Autism Dev Disord       Date:  2017-03

6.  CHRNA7 Deletions are Enriched in Risperidone-Treated Children and Adolescents.

Authors:  Madelyn A Gillentine; Janson J White; Christopher M Grochowski; James R Lupski; Christian P Schaaf; Chadi A Calarge
Journal:  J Child Adolesc Psychopharmacol       Date:  2017-08-17       Impact factor: 2.576

Review 7.  Genomic Disorders in Psychiatry-What Does the Clinician Need to Know?

Authors:  Chelsea Lowther; Gregory Costain; Danielle A Baribeau; Anne S Bassett
Journal:  Curr Psychiatry Rep       Date:  2017-09-20       Impact factor: 5.285

Review 8.  Regulation of aggressive behaviors by nicotinic acetylcholine receptors: Animal models, human genetics, and clinical studies.

Authors:  Alan S Lewis; Marina R Picciotto
Journal:  Neuropharmacology       Date:  2019-12-26       Impact factor: 5.250

9.  Transcriptomic networks implicate neuronal energetic abnormalities in three mouse models harboring autism and schizophrenia-associated mutations.

Authors:  Thomas Werge; Daniel H Geschwind; Aaron Gordon; Annika Forsingdal; Ib Vestergaard Klewe; Jacob Nielsen; Michael Didriksen
Journal:  Mol Psychiatry       Date:  2019-11-08       Impact factor: 15.992

10.  Altered neuronal physiology, development, and function associated with a common chromosome 15 duplication involving CHRNA7.

Authors:  Kesavan Meganathan; Ramachandran Prakasam; Dustin Baldridge; Paul Gontarz; Bo Zhang; Fumihiko Urano; Azad Bonni; Susan E Maloney; Tychele N Turner; James E Huettner; John N Constantino; Kristen L Kroll
Journal:  BMC Biol       Date:  2021-07-28       Impact factor: 7.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.